文献速递心脑血管急症重症综合管理与镇静镇痛

四种临床风险评分在院外心脏骤停后昏迷患者中的比较

Comparison of four clinical risk scores in comatose patients after out-of-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2023-08-25
一句话结论在TTM2试验事后分析中,TTM、MIRACLE2、CAHP评分对OHCA后6个月不良功能结局或死亡的判别能力较好(AUROC 0.81–0.835),但高特异度切点下敏感度均<40%。

本研究为TTM2试验的事后分析,比较OHCA、CAHP、MIRACLE2和TTM四种评分在院外心脏骤停后昏迷患者中的早期风险分层能力。主要终点为6个月不良功能结局或死亡(改良Rankin量表4–6分),共1829例有结局数据。MIRACLE2评分合并AUROC为0.810(95%CI 0.790–0.828),TTM评分为0.835(95%CI 0.816–0.852),CAHP评分为0.820(95%CI 0.800–0.839),OHCA评分为0.770(95%CI 0.748–0.791)。在特异度>95%所需切点下,四种评分敏感度均<40%。作者认为TTM、MIRACLE2和CAHP评分能提供足够准确的客观风险估计,可作为疑似心源性OHCA后整体患者评估的一部分;MIRACLE2评分因简单,可能是临床和试验风险分层的实用方案。

要点

  • 在1829例OHCA后昏迷患者中,6个月不良功能结局或死亡(mRS 4–6)的判别能力:TTM评分AUROC 0.835(95%CI 0.816–0.852),CAHP评分0.820(95%CI 0.800–0.839),MIRACLE2评分0.810(95%CI 0.790–0.828),OHCA评分0.770(95%CI 0.748–0.791)。
  • 在特异度>95%所需切点下,四种评分敏感度均<40%,高特异度切点不能用于排除不良结局。
  • 作者认为TTM、MIRACLE2和CAHP评分能提供足够准确的客观风险估计,可作为疑似心源性OHCA后整体患者评估的一部分。
  • 作者认为MIRACLE2评分因简单,可能是临床和试验风险分层的实用方案。

适用人群与场景

  • TTM2试验(院外心脏骤停后目标低温与目标常温比较)的事后分析人群,有6个月功能结局数据的1829例院外心脏骤停后昏迷患者。

研究设计与关键结果

  • 研究类型:TTM2试验的事后分析;缺失数据采用多重插补;主要终点为院外心脏骤停后6个月不良功能结局或死亡(改良Rankin量表4–6分)。
  • 共1829例有6个月功能结局数据,构成研究人群。
  • MIRACLE2评分合并AUROC为0.810(95%CI 0.790–0.828)。
  • TTM评分合并AUROC为0.835(95%CI 0.816–0.852)。
  • CAHP评分合并AUROC为0.820(95%CI 0.800–0.839)。
  • OHCA评分合并AUROC为0.770(95%CI 0.748–0.791)。
  • 在特异度>95%所需切点下,四种评分敏感度均<40%。

证据类型、等级与局限

  • 证据类型:TTM2试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为TTM、MIRACLE2和CAHP评分能提供足够准确的客观风险估计,可作为疑似心源性院外心脏骤停后整体患者评估的一部分。
  • 作者认为MIRACLE2评分因简单,可能是临床和试验风险分层的实用方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND AIMS: Several different scoring systems for early risk stratification after out-of-hospital cardiac arrest have been developed, but few have been validated in large datasets. The aim of the present study was to compare the well-validated Out-of-hospital Cardiac Arrest (OHCA) and Cardiac Arrest Hospital Prognosis (CAHP)-scores to the less complex MIRACLE2- and Target Temperature Management (TTM)-scores.

METHODS: This was a post-hoc analysis of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Missing data were handled by multiple imputation. The primary outcome was discriminatory performance assessed as the area under the receiver operating characteristics-curve (AUROC), with the outcome of interest being poor functional outcome or death (modified Rankin Scale 4-6) at 6 months after OHCA.

RESULTS: Data on functional outcome at 6 months were available for 1829 cases, which constituted the study population. The pooled AUROC for the MIRACLE2-score was 0.810 (95% CI 0.790-0.828), 0.835 (95% CI 0.816-0.852) for the TTM-score, 0.820 (95% CI 0.800-0.839) for the CAHP-score and 0.770 (95% CI 0.748-0.791) for the OHCA-score. At the cut-offs needed to achieve specificities >95%, sensitivities were <40% for all four scoring systems.

CONCLUSIONS: The TTM-, MIRACLE2- and CAHP-scores are all capable of providing objective risk estimates accurate enough to be used as part of a holistic patient assessment after OHCA of a suspected cardiac origin. Due to its simplicity, the MIRACLE2-score could be a practical solution for both clinical application and risk stratification within trials.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Schmidbauer S, Rylander C, Cariou A, et al. Comparison of four clinical risk scores in comatose patients after out-of-hospital cardiac arrest. Resuscitation. 2023. PMID: 37634862. doi:10.1016/j.resuscitation.2023.109949

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。